225 related articles for article (PubMed ID: 15802625)
1. A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65.
Zhang L; Ma Y; Zhang J; Cheng J; Du J
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1148-53. PubMed ID: 15802625
[TBL] [Abstract][Full Text] [Related]
2. Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase.
Zhang L; Cheng J; Ma Y; Thomas W; Zhang J; Du J
Circ Res; 2005 Nov; 97(10):975-82. PubMed ID: 16224066
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-kappaB through phosphorylation of IkappaBbeta.
Xu S; Bayat H; Hou X; Jiang B
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1336-45. PubMed ID: 16822942
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells.
Doyon P; Servant MJ
J Biol Chem; 2010 Oct; 285(40):30708-18. PubMed ID: 20659889
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
Joo JH; Jetten AM
J Biol Chem; 2008 Jun; 283(24):16391-9. PubMed ID: 18424438
[TBL] [Abstract][Full Text] [Related]
6. The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex.
Douillette A; Bibeau-Poirier A; Gravel SP; Clément JF; Chénard V; Moreau P; Servant MJ
J Biol Chem; 2006 May; 281(19):13275-13284. PubMed ID: 16513650
[TBL] [Abstract][Full Text] [Related]
7. siRNA knocks down Hsp27 and increases angiotensin II-induced phosphorylated NF-kappaB p65 levels in aortic smooth muscle cells.
Voegeli TS; Currie RW
Inflamm Res; 2009 Jun; 58(6):336-43. PubMed ID: 19247578
[TBL] [Abstract][Full Text] [Related]
8. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs.
Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR
Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103
[TBL] [Abstract][Full Text] [Related]
9. Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.
Chandrakesan P; Ahmed I; Anwar T; Wang Y; Sarkar S; Singh P; Peleg S; Umar S
J Biol Chem; 2010 Oct; 285(43):33485-33498. PubMed ID: 20710027
[TBL] [Abstract][Full Text] [Related]
10. Klotho Inhibits Proliferation and Migration of Angiotensin II-Induced Vascular Smooth Muscle Cells (VSMCs) by Modulating NF-κB p65, Akt, and Extracellular Signal Regulated Kinase (ERK) Signaling Activities.
Yu S; Chen Y; Chen S; Ye N; Li Y; Sun Y
Med Sci Monit; 2018 Jul; 24():4851-4860. PubMed ID: 30004089
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms.
Ruiz-Ortega M; Lorenzo O; Rupérez M; König S; Wittig B; Egido J
Circ Res; 2000 Jun; 86(12):1266-72. PubMed ID: 10864918
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.
Ma Y; Zhang L; Peng T; Cheng J; Taneja S; Zhang J; Delafontaine P; Du J
Endocrinology; 2006 Mar; 147(3):1256-63. PubMed ID: 16322063
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
Bokemeyer D; Schmitz U; Kramer HJ
Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1.
Abe K; Nakashima H; Ishida M; Miho N; Sawano M; Soe NN; Kurabayashi M; Chayama K; Yoshizumi M; Ishida T
Hypertens Res; 2008 May; 31(5):987-98. PubMed ID: 18712054
[TBL] [Abstract][Full Text] [Related]
15. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk.
Xu S; Zhi H; Hou X; Jiang B
Biochem Biophys Res Commun; 2011 Jul; 410(3):543-8. PubMed ID: 21683058
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells.
Morinelli TA; Lee MH; Kendall RT; Luttrell LM; Walker LP; Ullian ME
Am J Physiol Cell Physiol; 2013 Jun; 304(12):C1176-86. PubMed ID: 23576578
[TBL] [Abstract][Full Text] [Related]
18. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.
Ishida M; Ishida T; Nakashima H; Miho N; Miyagawa K; Chayama K; Oshima T; Kambe M; Yoshizumi M
Circ Res; 2003 Dec; 93(12):1218-24. PubMed ID: 14605021
[TBL] [Abstract][Full Text] [Related]
19. PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells.
Hsieh CY; Hsiao G; Hsu MJ; Wang YH; Sheu JR
J Cell Mol Med; 2014 Jul; 18(7):1278-89. PubMed ID: 24725826
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
